- Home
- CARV vs AIMD Comparison
CARV vs AIMD Comparison
Compare CARV & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- AIMD
- Stock Information
- Founded
- CARV 1948
- AIMD 1984
- Country
- CARV United States
- AIMD United States
- Employees
- CARV N/A
- AIMD N/A
- Industry
- CARV Savings Institutions
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- AIMD Health Care
- Exchange
- CARV Nasdaq
- AIMD Nasdaq
- Market Cap
- CARV 14.5M
- AIMD 16.9M
- IPO Year
- CARV 1994
- AIMD N/A
- Fundamental
- Price
- CARV $1.59
- AIMD $2.27
- Analyst Decision
- CARV
- AIMD
- Analyst Count
- CARV 0
- AIMD 0
- Target Price
- CARV N/A
- AIMD N/A
- AVG Volume (30 Days)
- CARV 62.7K
- AIMD 41.9K
- Earning Date
- CARV 11-13-2025
- AIMD 11-13-2025
- Dividend Yield
- CARV N/A
- AIMD N/A
- EPS Growth
- CARV N/A
- AIMD N/A
- EPS
- CARV N/A
- AIMD N/A
- Revenue
- CARV $22,310,000.00
- AIMD $113,037.00
- Revenue This Year
- CARV N/A
- AIMD N/A
- Revenue Next Year
- CARV N/A
- AIMD N/A
- P/E Ratio
- CARV N/A
- AIMD N/A
- Revenue Growth
- CARV N/A
- AIMD 178.19
- 52 Week Low
- CARV $1.30
- AIMD $1.78
- 52 Week High
- CARV $3.85
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- CARV 26.80
- AIMD 34.66
- Support Level
- CARV $1.41
- AIMD $1.78
- Resistance Level
- CARV $1.68
- AIMD $2.28
- Average True Range (ATR)
- CARV 0.26
- AIMD 0.22
- MACD
- CARV -0.22
- AIMD -0.03
- Stochastic Oscillator
- CARV 10.26
- AIMD 26.09
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.